Latest ORMP reports update at 2024-03-06: 2023 ∙ 2022
  1. Home
  2. Stock quotes
  3. Oramed Pharmaceuticals
  4. Financial Ratios
Oramed Pharmaceuticals logo
Oramed Pharmaceuticals ORMP
$ 2.35 0.21%
mail-toReport an Error

Oramed Pharmaceuticals Financial Ratios 2011-2024 | ORMP

Annual Financial Ratios Oramed Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 21.1 -2.3 -20.8 -5.3 -3.9 -5.7 -12.6 -8.4 -8.2 -13.2 -10.6 -6.8 -14.6

P/S

 86.9 31.5 94.4 22.4 20.6 29.6 53.8 143.0 - - - - -

EPS

 0.1 -0.9 0.8 0.6 0.8 0.9 0.8 0.9 0.7 0.6 0.6 0.6 -0.0

EV (Enterprise Value)

 107 M 44.6 M 228 M 53 M 67.6 M 83.8 M 148 M 104 M 57.5 M 74.4 M 43 M 19.7 M 21.8 M

EBITDA per Share

 -0.39 -1.04 -0.85 -0.506 -0.838 -0.909 -0.809 -0.793 -0.682 -0.638 -0.596 -0.488 -0.444

EV/EBITDA

 -6.2 -3.5 -3.6 -5.0 -11.9 -8.8 -7.6 -12.4 -9.9 -6.3 -8.8

PEG

 -5.38 -0.21 -2.98 -0.27 -0.83 0.64 -1.37 0.28 1.01 2.59 -6.35 0.05 -0.24

P/B

 0.5 0.5 1.4 1.8 2.9 2.3 6.9 3.5 2.4 3.6 5.5 6.0 6.1

P/CF

 -11.3 -3.0 -22.9 -4.8 -4.3 -4.9 -22.6 19.7 -12.0 -18.4 -13.2 -9.8 -13.6

ROE %

 3.37 -24.08 -7.36 -35.01 -74.02 -40.91 -54.48 -41.86 -29.13 -27.39 -52.05 -88.52 -41.92

ROA %

 2.51 -22.62 -6.89 -25.79 -41.41 -26.85 -27.07 -25.60 -27.44 -26.13 -48.87 -63.16 -36.09

ROCE %

 -9.37 -25.93 -14.22 -29.32 -49.84 -31.57 -32.11 -25.53 -29.69 -28.35 -52.73 -62.02 -62.69

Current Ratio

 - - - 8.9 6.3 6.8 3.9 8.6 11.7 22.4 17.4 8.2 9.7

DSO

 - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - 5422.3 -4817.2 1114.5 1051.1 - - - - -

Operating Cycle

 - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - -5422.3 4817.2 -1114.5 -1051.1 - - - - -

All numbers in USD currency

Quarterly Financial Ratios Oramed Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 0.08 0.03 0.08 - 0.18 0.27 0.27 0.31 0.21 0.12 0.2 0.3 0.44 0.1 0.23 0.15 0.69 0.23 0.15 0.25 0.68 0.3 0.25 0.18 0.59 0.15 0.18 0.2 0.5 0.15 0.2 0.21 0.48 0.15 0.21 0.19 0.45 0.18 0.19 0.14 0.49 0.17 0.14 0.14 0.34 0.09 0.01 0.01 0.01 -0.01 0.01

EBITDA per Share

 - - -0.13 - -0.21 -0.29 -0.29 -0.32 -0.21 -0.14 -0.29 -0.31 -0.45 -0.1 -0.25 -0.14 -0.7 -0.23 -0.14 -0.27 -0.72 -0.31 -0.27 -0.19 -0.6 -0.16 -0.19 -0.18 0.52 0.16 0.18 0.21 -0.49 -0.15 -0.21 -0.19 0.47 0.19 -0.19 -0.15 -0.47 -0.18 -0.13 -0.11 -0.33 -0.09 -0.12 -0.01 -0.03 -0.01 -0.01

ROE %

 -9.95 -12.40 -18.49 -18.09 -25.46 -26.97 -24.39 -22.55 -41.15 -60.93 -63.56 -78.55 -67.41 20.76 51.43 56.36 56.27 -37.50 -75.22 -75.31 -71.53 -80.49 -76.71 -72.94 -72.80 -8.65 9.19 10.26 10.64 -33.65 -47.65 -47.21 -44.61 -4.44 10.72 11.23 3.85 -58.03 -118.87 -123.58 -123.53 -169.74 -206.22 -217.77 -216.85 -170.26 -123.66 -111.13 -41.94 -41.92 -12.85

ROA %

 -8.71 -11.61 -17.34 -17.00 -23.89 -25.49 -23.85 -22.07 -33.06 -46.25 -46.51 -54.55 -44.84 9.07 25.94 31.08 29.38 -26.14 -47.07 -48.81 -45.03 -44.46 -40.35 -37.81 -37.59 -3.00 6.74 7.12 2.98 -30.91 -41.58 -44.50 -42.21 -4.14 10.25 10.62 4.30 -54.09 -111.34 -115.62 -115.63 -139.06 -153.36 -158.48 -156.70 -129.62 -102.55 -95.50 -36.09 -36.09 -11.06

ROCE %

 -12.84 -16.15 -21.04 -19.29 -26.53 -27.20 -24.49 -22.34 -36.56 -52.51 -53.56 -65.38 -53.08 -73.14 -82.50 -75.01 -77.61 -59.98 -55.53 -58.00 -53.74 -53.12 -48.96 -44.90 -43.37 -3.26 8.55 22.04 38.85 1.39 -10.56 -26.53 -45.39 -4.00 11.71 12.43 4.52 -56.67 -82.16 -87.34 -82.70 -83.80 -79.07 -80.49 -82.61 -88.14 -91.74 -88.00 -47.39 -15.23 -11.99

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 10.5 7.1 - 7.2 7.2 -

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - 1288.2 - - 2682.8 -1091.8 - 3388.0 - 662.7 662.7 - 344.3 -5364.7 - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - -1288.2 - - -2682.8 1091.8 - -3388.0 - -662.7 -662.7 - -344.3 5364.7 - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency